Is Insulet Stock a Good Investment?
Insulet Investment Advice | PODD |
- Examine Insulet's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Insulet's leadership team and their track record. Good management can help Insulet navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Insulet's business and its evolving consumer preferences.
- Compare Insulet's performance and market position to its competitors. Analyze how Insulet is positioned in terms of product offerings, innovation, and market share.
- Check if Insulet pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Insulet's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Insulet stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Insulet is a good investment.
Sell | Buy |
Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Insulet Stock
Researching Insulet's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 100.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 5.78. Insulet had not issued any dividends in recent years.
To determine if Insulet is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Insulet's research are outlined below:
| Insulet is unlikely to experience financial distress in the next 2 years | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Insulet announces pricing of senior notes due 2033 |
Insulet Quarterly Liabilities And Stockholders Equity |
|
Insulet uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Insulet. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Insulet's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Insulet's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Insulet's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-11-01 | 2018-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2020-05-07 | 2020-03-31 | -0.01 | -0.03 | -0.02 | 200 | ||
2019-11-05 | 2019-09-30 | 0.03 | 0.01 | -0.02 | 66 | ||
2017-05-08 | 2017-03-31 | -0.15 | -0.17 | -0.02 | 13 | ||
2014-08-07 | 2014-06-30 | -0.08 | -0.06 | 0.02 | 25 | ||
2023-02-23 | 2022-12-31 | 0.21 | 0.24 | 0.03 | 14 | ||
2020-02-25 | 2019-12-31 | 0.11 | 0.08 | -0.03 | 27 | ||
2016-04-28 | 2016-03-31 | -0.19 | -0.22 | -0.03 | 15 |
Know Insulet's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Insulet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insulet backward and forwards among themselves. Insulet's institutional investor refers to the entity that pools money to purchase Insulet's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Amvescap Plc. | 2024-12-31 | 1.2 M | Groupama Asset Management | 2024-12-31 | 1.1 M | Norges Bank | 2024-12-31 | 953 K | American Century Companies Inc | 2024-12-31 | 854.9 K | Artisan Partners Limited Partnership | 2024-12-31 | 770.2 K | Northern Trust Corp | 2024-12-31 | 738.8 K | Citadel Advisors Llc | 2024-12-31 | 729.1 K | Macquarie Group Ltd | 2024-12-31 | 691 K | William Blair Investment Management, Llc | 2024-12-31 | 676.3 K | Vanguard Group Inc | 2024-12-31 | 8.5 M | Fmr Inc | 2024-12-31 | 7.8 M |
Insulet's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 18.29 B.Market Cap |
|
Insulet's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.14 | 0.15 | |
| Return On Capital Employed | 0.12 | 0.13 | |
| Return On Assets | 0.14 | 0.14 | |
| Return On Equity | 0.35 | 0.36 |
Determining Insulet's profitability involves analyzing its financial statements and using various financial metrics to determine if Insulet is a good buy. For example, gross profit margin measures Insulet's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Insulet's profitability and make more informed investment decisions.
Insulet's Earnings Breakdown by Geography
Please note, the presentation of Insulet's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Insulet's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Insulet's management manipulating its earnings.
Evaluate Insulet's management efficiency
Insulet has return on total asset (ROA) of 0.068 % which means that it generated a profit of $0.068 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4303 %, meaning that it created $0.4303 on every $100 dollars invested by stockholders. Insulet's management efficiency ratios could be used to measure how well Insulet manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.15. The current year's Return On Capital Employed is expected to grow to 0.13. At present, Insulet's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.3 B, whereas Intangibles To Total Assets are forecasted to decline to 0.05.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 17.29 | 18.15 | |
| Tangible Book Value Per Share | 15.15 | 15.91 | |
| Enterprise Value Over EBITDA | 41.13 | 39.07 | |
| Price Book Value Ratio | 15.10 | 19.90 | |
| Enterprise Value Multiple | 41.13 | 39.07 | |
| Price Fair Value | 15.10 | 19.90 | |
| Enterprise Value | 9.8 B | 10.3 B |
Management at Insulet focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Beta 1.287 |
Basic technical analysis of Insulet Stock
As of the 19th of March, Insulet retains the Standard Deviation of 1.92, market risk adjusted performance of (0.1), and Risk Adjusted Performance of (0.02). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Insulet, as well as the relationship between them. Please check out Insulet information ratio, and the relationship between the coefficient of variation and value at risk to decide if Insulet is priced fairly, providing market reflects its last-minute price of 265.82 per share. Given that Insulet has information ratio of 0.0126, we strongly advise you to confirm Insulet's regular market performance to make sure the company can sustain itself at a future point.Insulet's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Insulet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Insulet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Insulet insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Insulet's Outstanding Corporate Bonds
Insulet issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Insulet uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Insulet bonds can be classified according to their maturity, which is the date when Insulet has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US45782BAD64 Corp BondUS45782BAD64 | View | |
| Installed Building Products Corp BondUS45780RAA95 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Insulet's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Insulet's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 1.38 | |||
| Coefficient Of Variation | (3,052) | |||
| Standard Deviation | 1.92 | |||
| Variance | 3.68 | |||
| Information Ratio | 0.0126 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | 0.1383 | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 9.83 | |||
| Value At Risk | (3.03) | |||
| Potential Upside | 3.5 | |||
| Skewness | (0.44) | |||
| Kurtosis | 1.84 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 1.38 | |||
| Coefficient Of Variation | (3,052) | |||
| Standard Deviation | 1.92 | |||
| Variance | 3.68 | |||
| Information Ratio | 0.0126 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | 0.1383 | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 9.83 | |||
| Value At Risk | (3.03) | |||
| Potential Upside | 3.5 | |||
| Skewness | (0.44) | |||
| Kurtosis | 1.84 |
Consider Insulet's intraday indicators
Insulet intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Insulet stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Insulet Corporate Filings
8K | 18th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 21st of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Insulet Stock media impact
Far too much social signal, news, headlines, and media speculation about Insulet that are available to investors today. That information is available publicly through Insulet media outlets and privately through word of mouth or via Insulet internal channels. However, regardless of the origin, that massive amount of Insulet data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insulet news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insulet relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insulet's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insulet alpha.
Insulet Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Insulet can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Insulet Historical Investor Sentiment
Investor biases related to Insulet's public news can be used to forecast risks associated with an investment in Insulet. The trend in average sentiment can be used to explain how an investor holding Insulet can time the market purely based on public headlines and social activities around Insulet. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insulet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insulet and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Insulet news discussions. The higher the estimate score, the more favorable the investor's outlook on Insulet.
Insulet Maximum Pain Price Across June 20th 2025 Option Contracts
Insulet's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Insulet close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Insulet's options.
Insulet Corporate Management
| Philip Hildale | Senior Care | Profile | |
| Andrew Isaacson | Senior Development | Profile | |
| Patrick Crannell | Senior Manager | Profile | |
| Prem Singh | Senior Operations | Profile | |
| Laetitia Cousin | Quality Affairs | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 5.78 | Revenue Per Share | Quarterly Revenue Growth 0.172 | Return On Assets |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Insulet's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.